| Application no. and date | 01949791.6 (espacenet) (Federated) (European Patent Register), 20010720 | | Patent/reg. no. and date | DK/EP 1301526, 20080618 | | Publication date | 20030416 | | Priority no. and date | GB 0017988, 20000721 | | EP pub. no. and date |
EP 1301526 20030416 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB6 ONN, GB | | Applicant ref. no. | 152142 | | Inventor | ALBINSON, Frederick David,
GlaxoSmithKline, Gunnels Wood Road
Stevenage,
Hertfordshire SG1 2NY, GB,
COOTE, Steven John,
GlaxoSmithKline, Gunnels Wood Road
Stevenage,
Hertfordshire SG1 2NY, GB,
ROBINSON, John Malcolm,
GlaxoSmithKline, Gunnels Wood Road
Stevenage,
Hertfordshire SG1 2NY, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C07J 3/00 (2006.01) , C07J 31/00 (2006.01) , C07J 5/00 (2006.01) | | Title | Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre | | Int. application no. | GB2001003289 | | Int. publication no. | WO2002008243 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
